Discovery of TAK-981, a First-in-Class Inhibitor of SUMO-Activating Enzyme for the Treatment of CancerSteven Langston, Xiaofeng Yang, Nancy J. Bump et al.|Journal of Medicinal Chemistry|2021Cited by 205
Design and Optimization of Potent and Orally Bioavailable Tetrahydronaphthalene Raf InhibitorsAlexandra E. Gould, Katherine Galvin, Ruth Adams et al.|Journal of Medicinal Chemistry|2011Cited by 33
Discovery and optimization of pyrazoline compounds as B-Raf inhibitorsMatthew O. Duffey, Qin Zhang, Ruth Adams et al.|Bioorganic & Medicinal Chemistry Letters|2010Cited by 15